Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vanda Pharmaceuticals Inc (NASDAQ:VNDA)

15.90
Delayed Data
As of 4:00pm ET
 +0.50 / +3.25%
Today’s Change
6.91
Today|||52-Week Range
18.00
+70.78%
Year-to-Date
AstraZeneca (AZN) Presents Tagrisso Data at Medical Meeting
Dec 07 / Zacks.com - Paid Partner Content
Novo Nordisk Files Regulatory Application for Semaglutide
Dec 06 / Zacks.com - Paid Partner Content
Sage Therapeutics Stock Up on SAGE-547 Regulatory Update
Dec 07 / Zacks.com - Paid Partner Content
Acceleron, Celgene Present Myelodysplastic Syndromes Data
Dec 05 / Zacks.com - Paid Partner Content
Theravance Stock Up on Fast Track Status for Velusetrag
Dec 07 / Zacks.com - Paid Partner Content
Alnylam Reports Positive Data on Fitusiran, Givosiran
Dec 05 / Zacks.com - Paid Partner Content
Bristol-Myers Reports Data from Opdivo Combination Studies
Dec 06 / Zacks.com - Paid Partner Content
Incyte Jakafi Positive in Pooled Analysis of Five-Year Data
Dec 05 / Zacks.com - Paid Partner Content
GW Pharma (GWPH) Posts Narrower-than-Expected Q4 Loss
Dec 06 / Zacks.com - Paid Partner Content
Alexion Presents Data from Ultra-Rare Blood Disorder Study
Dec 05 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close15.40
Today’s open15.45
Day’s range15.05 - 15.95
Volume470,461
Average volume (3 months)781,395
Market cap$676.8M
Dividend yield--
Data as of 4:00pm ET, 12/08/2016

Growth & Valuation

Earnings growth (last year)-270.91%
Earnings growth (this year)+101.11%
Earnings growth (next 5 years)+19.10%
Revenue growth (last year)+119.16%
P/E ratioNM
Price/Sales3.58
Price/Book4.96

Competitors

 Today’s
change
Today’s
% change
SCMPSucampo Pharmaceutic...+0.27+1.84%
MACKMerrimack Pharmaceut...+0.07+1.29%
ITCIIntra-Cellular Thera...-0.24-1.48%
ACIUAC Immune Ltd+0.40+3.43%
Data as of 4:00pm ET, 12/08/2016

Financials

Next reporting dateFebruary 14, 2017
EPS forecast (this quarter)$0.06
Annual revenue (last year)$109.9M
Annual profit (last year)-$39.9M
Net profit margin-36.27%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mihael Hristos Polymeropoulos
Chief Financial Officer, Treasurer &
Senior VP
James Patrick Kelly
Corporate headquarters
Washington, District Of Columbia

Forecasts


Search for Jobs